CEO Mark J Foley sold $2.2M of Revance Therapeutics, Inc.

Sold$2,223,360

$31.59Price

70,390Shares

−7%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Mar 9. Filed Thu, Mar 9, 4:45 PM ET, after the close. Not investment advice.